The downstream targets of AKT include GSK3β, mTOR,FOXO transcription factors and NFκB, all of which are involved in cardiac hypertrophy [10], [27], [29], [30], [31], [32], [33]. This evidence concerns the gene AKT1 and cardiac hypertrophy.